Therapie des Mammakarzinoms – Aktuelle adjuvante Therapiekonzepte bei Brusttumoren

• Literatur

• 1 Lattrich C. Therapie von Mammakarzinomen. TumorDiagn u Ther 2010; 31: 324-327
• 2 Berry DA et al. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA 2006; 295 (14) 1658-1667
• 3 Vaidya JS et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 2010; 376: 91-102
• 4 Haviland JS et al. The UK START (Standardisation of Breast Radiotherapy) Trials: 10-Year Follow-Up Results. Cancer Res 2012; 72 (Suppl. 24)
• 5 http://www.adjuvantonline.com
• 6 Smith I et al. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet 2007; 369: 29-36